Insight Molecular Diagnostics (IMDX) Operating Income Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Operating Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 33.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -18.11% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.63% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.57% |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | 35.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.09% |
| Dec 31, 2025 | 16.81% |
| Sep 30, 2025 | 18.25% |
| Jun 30, 2025 | -112.48% |
| Mar 31, 2025 | 26.63% |
| Dec 31, 2024 | 190.70% |
| Sep 30, 2024 | -107.51% |
| Jun 30, 2024 | 44.15% |
| Mar 31, 2024 | -258.41% |
| Dec 31, 2023 | -38.90% |
| Sep 30, 2023 | -281.77% |
| Jun 30, 2023 | -410.09% |
| Mar 31, 2023 | 293.90% |
| Dec 31, 2022 | 67.35% |
| Sep 30, 2022 | 87.46% |
| Jun 30, 2022 | 88.02% |
| Mar 31, 2022 | 73.44% |
| Dec 31, 2021 | -469.33% |
| Sep 30, 2021 | -117.87% |
| Jun 30, 2021 | -54.74% |